Literature DB >> 1304740

Cytokine inter-relationships and their association with disease activity in arthritis.

I Holt1, R G Cooper, J Denton, A Meager, S J Hopkins.   

Abstract

In order to investigate the relationships between cytokine production and arthritic disease we have determined the concentrations of immunoreactive interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-6, tumour necrosis factor-alpha (TNF-alpha), interferon-alpha (IFN-alpha), IFN-gamma, and soluble IL-2-receptor (sIL-2R), as well as bioactive IL-1 and IL-6, in synovial fluids (SF) and plasma of patients with a variety of arthritides. Careful assay revealed only minimal concentrations of IL-1, particularly its biologically active form, in SF. No IL-1 was detectable in the plasma of patients that had IL-1 in their SF. Concentrations of both immunoreactive IL-1 beta and TNF-alpha in SF of rheumatoid arthritis (RA) patients were significantly higher than those in SF from patients with other inflammatory arthritides or osteoarthritis (OA). IL-6 and sIL-2R concentrations in both SF and plasma were higher in RA patients than in OA patients, and were significantly correlated. Approximately half of the SF from patients with all arthropathies contained detectable IFN-alpha, whilst IFN-Y was present in less than 10%. There were significant associations between IL-6, sIL-2R, IL-1 beta, TNF-alpha and IFN-alpha. The concentration of these cytokines, where detectable, was also related to leukocyte counts in the SF, as well as to parameters assessing local and systemic disease activity. Although IL-6 was the cytokine most clearly related to other cytokines, and to parameters assessing disease activity, the relationship between general articular disease activity and IL-6 was only evident in patients with arthropathies other than rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304740     DOI: 10.1093/rheumatology/31.11.725

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  22 in total

1.  Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.

Authors:  Cindy Zer; George Sachs; Jai Moo Shin
Journal:  Physiol Genomics       Date:  2007-07-24       Impact factor: 3.107

Review 2.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

3.  Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis.

Authors:  A Spadaro; E Taccari; F Sensi; V Riccieri; A Sili Scavalli; A Zoppini
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 4.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

5.  Theory of signs and statistical approach to big data in assessing the relevance of clinical biomarkers of inflammation and oxidative stress.

Authors:  Pietro Ghezzi; Kevin Davies; Aidan Delaney; Luciano Floridi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

6.  The timing of glucocorticoid administration in rheumatoid arthritis.

Authors:  N G Arvidson; B Gudbjörnsson; A Larsson; R Hällgren
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

7.  The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis.

Authors:  A C Issekutz; A Meager; I Otterness; T B Issekutz
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.

Authors:  B A Eberhard; R M Laxer; U Andersson; E D Silverman
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.

Authors:  N G Arvidson; B Gudbjörnsson; L Elfman; A C Rydén; T H Tötterman; R Hällgren
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

10.  Inhibition of P2X4 suppresses joint inflammation and damage in collagen-induced arthritis.

Authors:  Faxin Li; Nongjian Guo; Yuxia Ma; Bin Ning; Yan Wang; Liqing Kou
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.